- Home
- TREE vs ABVX Comparison
TREE vs ABVX Comparison
Compare TREE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- ABVX
- Stock Information
- Founded
- TREE 1996
- ABVX 2013
- Country
- TREE United States
- ABVX France
- Employees
- TREE N/A
- ABVX N/A
- Industry
- TREE Finance: Consumer Services
- ABVX
- Sector
- TREE Finance
- ABVX
- Exchange
- TREE Nasdaq
- ABVX Nasdaq
- Market Cap
- TREE 482.0M
- ABVX 511.3M
- IPO Year
- TREE N/A
- ABVX N/A
- Fundamental
- Price
- TREE $38.99
- ABVX $7.90
- Analyst Decision
- TREE Buy
- ABVX Buy
- Analyst Count
- TREE 8
- ABVX 4
- Target Price
- TREE $64.13
- ABVX $31.50
- AVG Volume (30 Days)
- TREE 240.1K
- ABVX 254.8K
- Earning Date
- TREE 07-24-2025
- ABVX 08-11-2025
- Dividend Yield
- TREE N/A
- ABVX N/A
- EPS Growth
- TREE N/A
- ABVX N/A
- EPS
- TREE N/A
- ABVX N/A
- Revenue
- TREE $972,179,000.00
- ABVX $11,444,012.00
- Revenue This Year
- TREE $11.20
- ABVX $284.20
- Revenue Next Year
- TREE $7.39
- ABVX N/A
- P/E Ratio
- TREE N/A
- ABVX N/A
- Revenue Growth
- TREE 51.96
- ABVX 128.98
- 52 Week Low
- TREE $33.50
- ABVX $4.77
- 52 Week High
- TREE $62.49
- ABVX $14.16
- Technical
- Relative Strength Index (RSI)
- TREE 59.21
- ABVX 65.79
- Support Level
- TREE $36.38
- ABVX $7.41
- Resistance Level
- TREE $36.95
- ABVX $8.13
- Average True Range (ATR)
- TREE 1.33
- ABVX 0.45
- MACD
- TREE 0.64
- ABVX 0.12
- Stochastic Oscillator
- TREE 91.48
- ABVX 93.03
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.